National Academy of Medicine

Member Profiles

Leadership Consortium for Value & Science-Driven Health Care

Chair

  • Mark McClellan, MD, PhD

    Mark McClellan, MD, PhD, is a senior fellow and director of the Health Care Innovation and Value Initiative at the Brookings Institution. Within Brookings, his work focuses on promoting quality and value in patient centered health care. A doctor and economist by training, he also has a highly distinguished record in public service and in academic research. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care. Dr. McClellan chairs the FDA’s Reagan-Udall Foundation, is co-chair of the Quality Alliance Steering Committee, sits on the National Quality Forum’s Board of Directors, is a member of the Institute of Medicine, and is a research associate at the National Bureau of Economic Research. He previously served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and was an associate professor of economics and medicine at Stanford University.

Members

  • David Blumenthal, MD, MPP

    David Blumenthal, MD, MPP, became President and CEO of the Commonwealth Fund, a national health care philanthropy based in New York City, in January, 2013. Previously, he served as Chief Health Information and Innovation Officer at Partners Health System in Boston, MA, and was Samuel O. Thier Professor of Medicine and Professor of Health Care Policy at Massachusetts General Hospital/ Harvard Medical School. From 2009 to 2011, Dr. Blumenthal was the National Coordinator for Health Information Technology under President Barack Obama. In this role he was charged with building an interoperable, private and secure nationwide health information system and supporting the widespread, meaningful use of health IT. Prior to that, Dr. Blumenthal was a practicing primary care physician, director of the Institute for Health Policy, and professor of medicine and health policy at Massachusetts General Hospital/Partners Healthcare System and Harvard Medical School. As a renowned health services researcher and national authority on health IT adoption, Dr. Blumenthal has authored over 250 scholarly publications, including the seminal studies on the adoption and use of health information technology in the United States. Dr. Blumenthal received his undergraduate, medical, and public policy degrees from Harvard University and completed his residency in internal medicine at Massachusetts General Hospital.

  • Susan DeVore, MS

    Susan DeVore is president and CEO of the Premier healthcare alliance, the nation’s leading alliance of hospitals, health systems and other providers dedicated to improving healthcare performance. An alliance of more than 2,600 hospitals and health systems and more than 84,000 non-acute care sites, Premier uses the power of collaboration to lead the transformation to high quality, cost-effective healthcare. Premier membership includes more than 40 percent of all U.S. health systems.

    With the ultimate goal of helping its members improve the health of their local communities, Premier builds, tests and scales models that improve quality, safety and cost of care. Through successful initiatives such as the Hospital Quality Incentive Demonstration™ with CMS, and QUEST®: High Performing Hospitals collaborative, the alliance has driven improvements in evidence-based care and safety, as well as significant reductions in mortality, harm and cost. Premier is a leader in the accountable care movement and is working in a joint venture with IBM to develop industry-leading population analytics tools.

    Under DeVore’s leadership, Premier has built an industry leading code of ethics, has been named five times as one of the World’s Most Ethical Companies by Ethisphere and has won the Malcolm Baldrige National Quality Award. DeVore is an industry leading thinker who was named to Modern Healthcare’s inaugural list of top 25 women in healthcare. She is on the board of the Healthcare Leadership Council and the Medicare Rights Center, as well as the executive committee of the Charlotte Chamber of Commerce.

  • Judith Faulkner, MS

    Judith R. Faulkner, MS, is CEO and founder of Epic Systems Corporation. With a BS in Mathematics from Dickinson College, an MS and an honorary doctorate in Computer Science from the University of Wisconsin, she taught computer science for several years in the UW system and then worked as a healthcare software developer, creating one of the first databases organized around a patient record. She founded Epic in 1979 and guided it from its modest beginnings as a clinical database company to its current place as a leading provider of integrated healthcare software.

    Epic was rated the #1 overall software vendor by KLAS and is in the Leaders Quadrant of Gartner’s Magic Quadrant for U.S. Enterprise CPR Systems. Judy was honored by HIMSS as one of the “50 in 50” memorable contributors to healthcare IT throughout HIMSS’s 50-year history. She currently serves on the HIT Policy Committee, the Privacy and Security sub-committee, the University of Wisconsin Computer Science Board of Visitors, and the Institute of Medicine’s Roundtable on Value & Science-Driven Health Care.

  • David T. Feinberg, MD, MBA

    David T. Feinberg is president and chief executive officer of Geisinger Health System. A vertically integrated, physician-led system, Geisinger is widely recognized as a leader in the implementation and use of the electronic health record and the development of innovative care models to enhance patient care. Dr. Feinberg previously served as CEO of UCLA’s hospitals and associate vice chancellor of UCLA Health Sciences, as well as president of UCLA Health System.

    Named to the 100 Most Influential People in Healthcare as well as the 50 Most Influential Physician Executives and Leaders by Modern Healthcare, Dr. Feinberg is triple board certified in Child and Adolescent Psychiatry, Adult Psychiatry and Addiction Psychiatry.

    Dr. Feinberg’s numerous awards and recognitions include the Medical Center CEO of the Year Leadership, Vision and Commitment Honoree by the National Health Foundation; Distinguished Fellow of the American Psychiatric Association, and the Cancro Academic Leadership Award from the American Academy of Child & Adolescent Psychiatry. A member of the Alpha Omega Alpha Medical Honor Society, he has published numerous professional articles and chapters and is a leading speaker on a variety of topics, including the patient experience, attention deficit and hyperactivity disorder, autism, pediatric bipolar disorder, pediatric depression, adolescent substance abuse and the industrialization of medicine.

  • Joseph J. Fifer, FHFMA, CPA

    Joe Fifer, FHFMA, CPA, is president and chief executive officer of the Healthcare Financial Management Association. HFMA provides the resources healthcare organizations need to achieve sound fiscal health in order to provide excellent patient care. With more than 39,000 members, HFMA is the nation’s leading membership organization of healthcare finance executives and leaders. Prior to assuming this position in June 2012, Fifer spent 11 years as vice president of hospital finance at Spectrum Health, in Grand Rapids, Mich. Mr. Fifer also spent time with McLaren Health Care Corporation, Flint, Mich., as vice president of finance and Ingham Regional Medical Center, Lansing, Mich., as senior vice president of finance and CFO. Mr. Fifer started his career with nine years at Ernst and Young, also in Michigan. Fifer was Chair of the HFMA Board of Directors in 2006-07. An HFMA member since 1983, Fifer served as a chapter president and for two terms as an HFMA board member. A Fellow of HFMA and a CPA, Fifer received his bachelor’s degree in Business Administration from Saginaw Valley State University, University Center, Mich. Fifer is an active community volunteer and runner. Fifer and his wife, Katie, have three children: Sarah, Tom, and Joe-Joe.

  • Patricia A. Gabow, MD, MACP

    Patricia A. Gabow, MD, is CEO of Denver Health, a highly-regarded integrated healthcare system. Author of over 150 publications, Dr. Gabow is Professor of Medicine, University of Colorado School of Medicine. She received her MD degree from the University of Pennsylvania School of Medicine. She has received the AMA Nathan Davis Award for Outstanding Public Servant, the National Healthcare Leadership Award and the David E. Rogers Award from AAMC. She is a member of The Commonwealth Commission for a High Performing Health System and of the federal Medicaid and CHIP Payment and Access Commission (MACPAC).

  • Atul Gawande, MD, MPH

    Atul Gawande, MD, MPH became a staff writer at The New Yorker in 1998. Also a general and endocrine surgeon, he practices surgery at Brigham and Women’s Hospital in Boston. He is Associate Professor of Surgery at Harvard Medical School and Associate Professor in the Department of Health Policy and Management at the Harvard School of Public Health.

    His research work focuses on systems innovations to transform safety, cost, and performance in health care. He serves as lead advisor for the World Health Organization’s safe surgery and safe childbirth programs. He is also founder and chairman of Lifebox (www.lifebox.org), an international not-for-profit implementing systems and technologies to reduce surgical deaths globally.

    He has written three New York Times bestselling books: COMPLICATIONS, which was a finalist for the National Book Award in 2002; BETTER, which was selected as one of the ten best books of 2007 by Amazon.com; and THE CHECKLIST MANIFESTO. He has won two National Magazine Awards, AcademyHealth’s Impact Award for highest research impact on health care, a MacArthur Award, and selection by Foreign Policy Magazine and TIME magazine as one of the world’s top 100 influential thinkers.

    • Julie L. Gerberding, MD, MPH

      Julie L. Gerberding is Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at Merck & Co., Inc., where she also has responsibility for the Merck for Mothers program and the Merck Foundation. As Chief Patient Officer, Dr. Gerberding leads efforts to engage with patients and patient organizations to bring their perspectives into Merck and MSD to help inform company decisions and represents Merck globally on patient-related matters. In addition, she is building new initiatives designed to accelerate Merck’s ability to contribute to improved population health, a measure increasingly valued by consumers, health organizations, and communities. As a world-renowned infectious disease and public health expert, Dr. Gerberding is a leader well-versed in and passionate about acting with purpose and urgency to meet patient needs. She joined Merck in January 2010 as president of Merck Vaccines and, during her leadership of that business, helped make the company’s vaccines increasingly more available and affordable to people in emerging markets and some of the most resource-limited countries in the world.

      Dr. Gerberding also helped lead the successful launch in India of the MSD Wellcome Trust Hilleman Laboratories, a not-for-profit joint venture for vaccine development. In 1998, she left her tenured academic faculty appointment at the University of California, San Francisco, to lead the U.S. Centers for Disease Control and Prevention (CDC) Division of Healthcare Quality Promotion and then served as the CDC Director from 2002 to 2009. As director, Dr. Gerberding led the CDC through more than 40 emergency responses to public health crises, including anthrax bioterrorism, SARS, and natural disasters. She also advised governments around the world on urgent issues such as pandemic preparedness, AIDS, antimicrobial resistance, tobacco, and cancer. At the University of California, San Francisco (UCSF), Dr. Gerberding directed the Prevention Epicenter, a multidisciplinary research, training, and clinical service program that focused on the prevention of infections in patients and their healthcare providers. Dr. Gerberding received her undergraduate and M.D. degrees from Case Western Reserve University (CWRU). She completed her internship and residency in Internal Medicine and fellowship in Clinical Pharmacology and Infectious Diseases at the University of California, San Francisco (UCSF), where she is currently an Adjunct Associate Clinical Professor of Medicine in Infectious Diseases.

      Dr. Gerberding received a Masters of Public Health at the University of California, Berkeley. She is a member of the Institute of Medicine and a fellow of the Infectious Diseases Society of America and the American College of Physicians, and is board certified in Internal Medicine and Infectious Diseases. Dr. Gerberding currently serves on the Boards of CWRU, National Association of City and County Health Officials (NACCHO) Foundation, MSD Wellcome Trust Hilleman Laboratories, and the BIO Executive Committee. Dr. Gerberding has received more than 50 awards and honors, including the United States Department of Health and Human Services (DHHS) Distinguished Service Award for her leadership in responses to anthrax bioterrorism and the September 11, 2001 attacks. She was named to Forbes Magazine’s 100 Most Powerful Women in the World in 2005 through 2008 and to TIME Magazine’s 100 Most Influential People in the World in 2004.

    • Brent C. James, MD, Mstat

      Brent C. James, MD, MStat is the Chief Quality Officer and Executive Director, Institute for Health Care Delivery Research at Intermountain Healthcare. Intermountain is an integrated system of 23 hospitals, almost 150 clinics, a 700+ member physician group, and an HMO/PPO insurance plan jointly responsible for more than 500,000 covered lives serving patients in Utah, Idaho, and, at a tertiary level, seven surrounding States.

      Brent James is known internationally for his work in clinical quality improvement, patient safety, and the infrastructure that underlies successful improvement efforts, such as culture change, data systems, payment methods, and management roles.

      He is a member of the National Academy of Science’s Institute of Medicine (and participated in many of that organization’s seminal works on quality and patient safety).

      Dr. James was recently recognized for his pioneering work in applying quality improvement techniques that were originally developed by W. Edwards Deming and others and awarded the 2011 Deming Cup. The award is given annually to an individual who has made outstanding contributions in the area of operations and has established a culture of continuous improvement within his or her respective organization. Dr. James was instrumental in helping create and implement a “system” model at Intermountain, in which physicians study process and outcomes data to determine the types of care that are most effective.

      He holds faculty appointments at the University of Utah School of Medicine (Family Medicine and Biomedical Informatics), Harvard School of Public Health (Health Policy and Management), and the University of Sydney, Australia, School of Public Health.

      Through the Intermountain Advanced Training Program in Clinical Practice Improve-ment (ATP), he has trained more than 3500 senior physician, nursing, and administra-tive executives, drawn from around the world, in clinical management methods, with proven improvement results (and more than 30 “daughter” training programs in 6 countries) Before coming to Intermountain, he was an Assistant Professor in the Department of Biostatistics at the Harvard School of Public Health, providing statistical support for the Eastern Cooperative Oncology Group (ECOG); and staffed the American College of Surgeons’ Commission on Cancer.

      He holds Bachelor of Science degrees in Computer Science (Electrical Engineering) and Medical Biology; an M.D. degree (with residency training in general surgery and oncology); and a Master of Statistics degree. Dr. James serves on several non-profit boards of trustees, dedicated to clinical improvement.

    • Gary Kaplan, MD

      Gary Kaplan, MD, FACP, FACMPE has served as Chairman and CEO of the Virginia Mason Health System since 2000. Dr. Kaplan received his medical degree from the University of Michigan and is board-certified in internal medicine. Since Dr. Kaplan became Chairman and CEO, Virginia Mason has received significant national and international recognition for its efforts to transform health care. The Leapfrog Group named Virginia Mason “Top Hospital of The Decade” for patient safety and quality, a distinction shared with only one other hospital. For the fifth consecutive year, The Leapfrog Group also named Virginia Mason as one of 65 U.S. hospitals to be designated as a “Top Hospital”. In addition, Virginia Mason has received HealthGrades’ “Distinguished Hospital Award for Clinical Excellence” for five consecutive years. Virginia Mason is considered to be the national leader in deploying the Toyota Production System to health-care management – reducing the high costs of health care while improving quality, safety and efficiency to deliver better, faster, and more affordable care. In addition to his patient-care duties and position as CEO, Dr. Kaplan is a clinical professor at the University of Washington and has been recognized for his service and contribution to many regional and national boards, including the Institute for Healthcare Improvement, the Medical Group Management Association, the National Patient Safety Foundation, the Greater Seattle Chamber of Commerce and the Washington Healthcare Forum. Dr. Kaplan is a founding member of Health CEOs for Health Reform. In 2007, Dr. Kaplan was designated a fellow in the American College of Physician Executives. In 2011, he was named the 12th most influential U.S. physician leader in health care by Modern Healthcare magazine, and the same publication ranked Dr. Kaplan 33rd on its list of the “100 Most Influential People in Healthcare.” In 2012, he was named the 2nd most influential U.S. physician leader in health care by the same publication. In 2009, Dr. Kaplan received the John M. Eisenberg Award from the National Quality Forum and The Joint Commission for Individual Achievement at the national level for his outstanding work and commitment to patient safety and quality. Additionally, he was recognized by the Medical Group Management Association (MGMA) as the recipient of the Harry J. Harwick Lifetime Achievement Award. Each year, the MGMA and the American College of Medical Practice Executives honor one individual who has made outstanding nationally recognized contributions to health-care administration, delivery, and education in his career, advancing the field of medical practice management.

    • Gregory F. Kennan, MD

      Gregory F. Keenan, MD currently serves as a Member of the National Academy of Medicine Leadership Consortium on Value & Science Driven Health Care and on the Board of the National Pharmaceutical Council. Greg began his career as a pediatric and adult rheumatologist, holding faculty, hospital and fellowship appointments at the Children’s Hospital of Philadelphia and the Hospital of the University of Pennsylvania. He then spent more than ten years with Centocor, Inc., performing roles of increasing responsibility in the Medical Affairs Department supporting the biologic compounds within rheumatology, gastroenterology, and dermatology therapeutic areas. More recently, Greg served as the Vice President of Medical Affairs at Human Genome Services, Inc., launching the first biologic treatment for systemic lupus erythematosus. He joined MedImmune in 2012 as the Senior Vice President of Medical and Scientific Affairs. In this role, Greg led a team of multiple departments including the Medical Science Directors field based team, Research and Policy, Operations and Medical Information services to support Synagis and Flumist/Fluenz. Greg received his bachelor’s degree from Colby College and his medical degree from Albany Medical College. He is boarded in pediatric and adult rheumatology.

    • Darrell G. Kirch, MD

      Darrell G. Kirch, MD, is president and CEO of the Association of American Medical Colleges (AAMC), which represents the nation’s medical schools, teaching hospitals, and academic societies. A distinguished physician, educator, and medical scientist, Dr. Kirch speaks and publishes widely on the need for transformation in the nation’s health care system and how academic medicine can lead that change across medical education, medical research, and patient care. Prior to becoming AAMC president in 2006, Dr. Kirch served as the dean and academic health system leader of two institutions, the Medical College of Georgia and the Penn State Milton S. Hershey Medical Center. He has co-chaired the Liaison Committee on Medical Education, the accrediting body for U.S. medical schools, and now serves as a member-at-large of the National Board of Medical Examiners and as chair of the Department of Veterans Affairs Special Medical Advisory Group. Dr. Kirch also is a member of the Institute of Medicine of the National Academies. A psychiatrist and clinical neuroscientist by training, Dr. Kirch began his career at the National Institute of Mental Health, becoming the acting scientific director in 1993 and receiving the Outstanding Service Medal of the United States Public Health Service. A native of Denver, he earned his B.A. and M.D. degrees from the University of Colorado.

    • Richard E. Kuntz, MD, MS

      Rick Kuntz is Senior Vice President and Chief Scientific, Clinical and Regulatory Officer of Medtronic, Inc. In this role, which he assumed in August 2009, Dr. Kuntz oversees the company’s global regulatory affairs, health policy and reimbursement, clinical research activities, ventures and new therapies, strategy and innovation, corporate development, and acquisitions, integrations and divestitures functions.

      Dr. Kuntz joined Medtronic in October 2005, as Senior Vice President and President of Medtronic Neuromodulation, which encompasses the company’s products and therapies used in the treatment of chronic pain, movement disorders, spasticity, overactive bladder and urinary retention, benign prostatic hyperplasia, and gastroparesis. In this role he was responsible for the research, development, operations and product sales and marketing for each of these therapeutic areas worldwide.

      Dr. Kuntz brings to Medtronic a broad background and expertise in many different areas of healthcare. Prior to Medtronic he was the Founder and Chief Scientific Officer of the Harvard Clinical Research Institute (HCRI), a university-based contract research organization which coordinates National Institutes of Health (NIH) and industry clinical trials with the United States Food and Drug Administration (FDA). Dr. Kuntz has directed over 100 multicenter clinical trials and has authored more than 200 original publications. His major interests are traditional and alternative clinical trial design and biostatistics.

      Dr. Kuntz also served as Associate Professor of Medicine at Harvard Medical School, Chief of the Division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women’s Hospital in Boston, MA.

      Dr. Kuntz graduated from Miami University, and received his medical degree from Case Western Reserve University School of Medicine. He completed his residency in internal medicine at the University of Texas Southwestern Medical School, and then completed fellowships in cardiovascular diseases and interventional cardiology at the Beth Israel Hospital and Harvard Medical School, Boston. Dr. Kuntz received his master’s of science in biostatistics from the Harvard School of Public Health.

    • Peter Long, PhD

      Peter Long, PhD, is the president and CEO of Blue Shield of California Foundation. He leads the Foundation in its mission to improve the lives of all Californians, particularly the underserved, by making health care accessible, effective, and affordable, and by ending domestic violence. In 2014, the Foundation awarded 481 grants totaling $31.8 million across California, making it one of the state’s largest grantmaking institutions. Prior to joining Blue Shield of California Foundation, Dr. Long served in leadership roles at the Henry J. Kaiser Family Foundation and The California Endowment. He has extensive experience working on health policy issues at the state, national, and global levels, and has written numerous papers on these topics. Dr. Long also served as the director of development and programs for the Indian Health Center of Santa Clara Valley in San Jose, before assuming his position there as executive director. Previously, in Cape Town, South Africa, Dr. Long served as a legislative analyst for the National Progressive Primary Health Care Network during the country’s transition to democracy. Outside of his role as CEO, Dr. Long is actively involved in multiple healthcare and professional organizations, serving on the Board of Directors for Grantmakers in Health and Grantmakers for Effective Organizations, and the Governance Board at the Institute for Clinical and Economic Review. He was one of the lead organizers of the Philanthropy-Joining Forces Impact Pledge, which raised more than $200 million for veterans and military families and is a member of the National Academy of Medicine’s Leadership Consortium for Value & Science-Driven Health Care. In addition, he practices as an adjunct professor at the University of California, Los Angeles Fielding School of Public Health. Dr. Long received a bachelor of arts degree from Harvard University; a master’s in health policy from The Johns Hopkins University School of Hygiene and Public Health; and his doctorate in health services from the University of California, Los Angeles. He currently lives in Orange County with his wife and three children.

    • James L. Madara, MD

      James L. Madara, MD, serves as executive vice president and chief executive officer of the American Medical Association (AMA), the nation’s largest physician organization. An accomplished academic medical center physician, medical scientist and administrator, Dr. Madara, prior to joining the AMA, served as Timmie Professor and chair of pathology and laboratory medicine at the Emory University School of Medicine before assuming the Thompson Distinguished Service Professorship and deanship at the University of Chicago Pritzker School of Medicine.

      During his deanship at Chicago, which also extended to the university’s renowned Biological Sciences Division, Dr. Madara also served as CEO of the University of Chicago Medical Center, bringing together the university’s biomedical research, teaching and clinical activities. As CEO, he engineered significant new affiliations with community hospitals, teaching hospital systems, community Federally Qualified Health Centers on Chicago’s South Side, as well as with national research organizations.

      While at the University of Chicago from 2002 to 2009, Dr. Madara oversaw a significant renewal of the institution’s biomedical campus, including the opening of the Comer Children’s Hospital, the New Hospital Pavilion for adults, the Gordon Center for Integrative Science and the Knapp Center for Biomedical Discovery.

      Dr. Madara is a noted academic pathologist and an authority on epithelial cell biology and on gastrointestinal disease. He has published more than 200 original papers and chapters, making important contributions to understanding the biology of the cells that line the digestive tract. His work has garnered both national and international awards.

      Dr. Madara has served as president of the American Board of Pathology and as editor-in-chief of the American Journal of Pathology. A past recipient of a prestigious MERIT Award from the National Institute of Health, he recently received the Davenport Award for lifetime achievement in gastrointestinal disease from the American Physiological Society.

      Most recently, Dr. Madara served as senior advisor with Leavitt Partners, a highly innovative health care consulting firm started by former Secretary of Health and Human Services Mike Leavitt.

      Dr. Madara earned his medical degree from Hahnemann Medical College in Philadelphia. He completed his internship and residency at New England Deaconess Hospital in Boston. He subsequently completed a fellowship in anatomy and cell biology at Peter Bent Brigham Hospital in Boston (now Brigham and Women’s Hospital). Following his fellowship, Dr. Madara joined the faculty of Harvard Medical School where he rose to a full tenured professor and served as director of the Harvard Digestive Diseases Center.

      Dr. Madara and his wife Vicki have two children: Max and Alexis.

    • Mark E. Miller, PhD

      With more than 18 years of health policy experience, Mark Miller, PhD, has held several important policy, research, and management positions in health care. Dr. Miller served as Assistant Director of Health and Human Resources (HHR) at the Congressional Budget Office (CBO). Prior to CBO, Dr. Miller was the Deputy Director of Health Plans at the Centers for Medicare and Medicaid Services (CMS, formerly the Health Care Financing Administration). Before CMS, Dr. Miller was the Health Financing Branch Chief at the Office of Management and Budget (OMB). Prior to joining OMB, Dr. Miller was a Senior Research Associate at the Urban Institute. He earned a Ph.D. in public policy analysis from the State University of New York at Binghamton.

    • Ameet Nathwani, MD

      A U.K. citizen, born in Uganda and educated in the U.K., Ameet Nathwani, MD qualified in medicine in 1987 in London, acquired his specialization in Cardiology at a number of University Hospitals in London, and has a diploma in Pharmaceutical Medicine and an executive Masters in Business Administration.

      Dr. Nathwani has more than 20 years of experience in the pharmaceutical industry beginning in 1994 when he joined Glaxo Group Research. From the period of 1994 to 2004 he held increasingly senior global functional and franchise leadership roles in research and development in Glaxo, SmithKline Beecham and GlaxoSmithKline, both in Europe and US. He joined Novartis in 2004 as the Senior Vice President and Global Development Head of the Cardiovascular and Metabolic Franchise and over the period of 11 years has held a number of senior development and commercial positions including the Global Head of the Critical Care Business Franchise. He was appointed as Global Head of Medical Affairs Novartis Pharma AG in June 2014 and became an extended member of the Pharma Executive Committee where he led the establishment of a Real World Evidence Center of Excellence and Digital Medicine capability.

    • Mary D. Naylor, PhD, FAAN, RN

      Mary D. Naylor, PhD, FAAN, RN, is the Marian S. Ware Professor in Gerontology and Director of the NewCourtland Center for Transitions and Health at the University of Pennsylvania School of Nursing. Since 1989, Dr. Naylor has led an interdisciplinary program of research designed to improve the quality of care, decrease unnecessary hospitalizations, and reduce health care costs for vulnerable community-based elders. Dr. Naylor is also the National Program Director for the Robert Wood Johnson Foundation program, Interdisciplinary Nursing Quality Research Initiative, aimed at generating, disseminating, and translating research to understand how nurses contribute to quality patient care. She was elected to the National Academy of Sciences, Institute of Medicine in 2005. She also is a member of the RAND Health Board, the National Quality Forum Board of Directors and the immediate past-chair of the Board of the Long-Term Quality Alliance. She was appointed to the Medicare Payment Advisory Commission in 2010.

      • William D. Novelli, MA

        William D. Novelli is a professor in the McDonough School of Business at Georgetown University. He teaches in the MBA program and has created and leads the Global Social Enterprise Initiative at the School. He also is Co-Chair of the Coalition to Transform Advanced Care (C-TAC), a national organization dedicated to reforming advanced illness care by empowering consumers, changing the health care delivery system, improving public policies and enhancing provider capacity. From 2001 to 2009, he was CEO of AARP, a membership organization of over 40 million people 50 and older. During his tenure, AARP achieved important policy successes at national and state levels in health, financial security, good government and other areas. It also doubled its budget, added five million new members and expanded internationally.

        Prior to AARP, Mr. Novelli was President of the Campaign for Tobacco-Free Kids, whose mandate is to change public policies and the social environment, limit tobacco companies’ marketing and sales practices to children and serve as a counterforce to the tobacco industry and its special interests. He now serves as chairman of the board.

        Previously, he was Executive Vice President of CARE, the world’s largest private relief and development organization. He was responsible for all operations in the U.S. and abroad. CARE helps impoverished people in Africa, Asia and Latin America through programs in health, agriculture, environmental protection and small business support. CARE also provides emergency relief to people in need.

        Earlier, Mr. Novelli co-founded and was President of Porter Novelli, now one of the world’s largest public relations agencies and part of the Omnicom Group, an international marketing communications corporation. He directed numerous corporate accounts as well as the management and development of the firm. Porter Novelli was founded to apply marketing to social and health issues, and grew into an international marketing/public relations agency with corporate, not-for-profit and government clients. He retired from the firm in 1990 to pursue a second career in public service. He was named one of the 100 most influential public relations professionals of the 20th century by the industry’s leading publication.

        Mr. Novelli is a recognized leader in social marketing and social change, and has managed programs in cancer control, diet and nutrition, cardiovascular health, reproductive health, infant survival, pay increases for educators, charitable giving and other programs in the U.S. and the developing world.

        He began his career at Unilever, a worldwide-packaged goods marketing company, moved to a major ad agency, and then served as Director of Advertising and Creative Services for the Peace Corps. In this role, Mr. Novelli helped direct recruitment efforts for the Peace Corps, VISTA, and social involvement programs for older Americans.

        He holds a B.A. from the University of Pennsylvania and an M.A. from Penn’s Annenberg School for Communication, and pursued doctoral studies at New York University. He taught marketing management for 10 years in the University of Maryland’s M.B.A. program and also taught health communications there. He has lectured at many other institutions. He has written numerous articles and chapters on marketing management, marketing communications, and social marketing in journals, periodicals and textbooks.

        His book, 50+: Give Meaning and Purpose to the Best Time of Your Life, was updated in 2008. His newest book, Managing the Older Worker: How to Prepare for the New Organizational Order (with Peter Cappelli) was published in 2010.

        Mr. Novelli serves on a number of boards and advisory committees. He and his wife, Fran, live in Bethesda, Maryland. They have three adult children and seven grandchildren.

      • Sally Okun, BSN, RN, MMHS

        Sally Okun is the Vice President for Advocacy, Policy and Patient Safety at PatientsLikeMe, an online patient powered research network. She is responsible for bringing patient voice and insight to diverse advocacy and health policy discussions at the national and global level, and is the company’s liaison with government and regulatory agencies. Ms. Okun joined the company in 2008 as the manager of Health Data Integrity and Patient Safety overseeing the site’s medical ontology and the development of the PatientsLikeMe Drug Safety and Pharmacovigilance Platform. She is frequently sought as a member of numerous advisory boards and expert panels including the PCORI Patient Engagement Advisory Panel, Scientific Advisory Committee for Reagan-Udall Foundation’s IMEDS program, National Academy of Medicine, National Quality Forum, Agency for Health Care Research and Quality, The Commonwealth Fund, and others. She is the co-chair for the Precision Medicine Initiative’s Engagement and Communications Work Group. Ms. Okun, a Registered Nurse and palliative care specialist, received her Master’s degree from The Heller School for Social Policy & Management at Brandeis University, was a 2010 fellow at the National Library of Medicine Program in Biomedical Informatics and a 2014 Salzburg Global Fellow.

        • Harold Paz, MD, MS

          Harold L. Paz, MD, MS, is executive vice president and chief medical officer for Aetna. He leads clinical strategy and policy at the intersection of all of Aetna’s domestic and global businesses. He is responsible for driving clinical innovation to improve member experience, quality and cost in all areas of the health care delivery system. Reporting to Aetna’s Chairman and CEO, he is a member of the company’s executive committee.

          Before joining Aetna in 2014, Dr. Paz served as chief executive officer of Penn State Hershey Medical Center and Health System, senior vice president for Health Affairs for Penn State University, dean of its College of Medicine and professor of medicine and public health sciences for eight years. His vision for health care transformation at Penn State led to the formation of an integrated healthcare system of four hospitals, 64 ambulatory care practices and 18 affiliated hospitals focused on population health across central Pennsylvania. Prior to his appointment to Penn State, he spent 11 years as dean of the Robert Wood Johnson Medical School and chief executive officer of Robert Wood Johnson University Medical Group, the largest multispecialty group practice in New Jersey where he was professor of medicine.

          Dr. Paz has focused his research and teaching on clinical outcomes, health care effectiveness and personalized health. A pioneer in the field of quality management, Dr. Paz was among the first to study clinical outcomes in the intensive care unit. From this early work, he recognized the need to formally train physicians in quality, and in 1993 he started the first fellowship of its kind in quality management. Currently, he is professor adjunct of internal medicine at Yale University School of Medicine and remains clinically active in pulmonary medicine at the West Haven Veterans Administration Hospital. He serves on the National Academy of Medicine (NAM) Leadership Consortium and the NAM Roundtable on Quality Care for People with Advanced Illness.
          A fellow of the American College of Physicians and the American College of Chest Physicians, Dr. Paz is currently on the boards of Select Medical Corporation, United Surgical Partners International, Research!America and the National Health Council. Dr. Paz is past chair of the Board of Directors of the Association of Academic Health Centers and a former member of the Association of American Medical Colleges (AAMC) and the University Health System Consortium boards of directors. He previously was chair of the AAMC Council of Deans administrative board and has served on the AAMC executive council, in addition to corporate and scientific advisory boards in the biotechnology field. He has authored over 100 publications, including peer-reviewed research and quality articles, chapters, commentaries and abstracts. He is the recipient of numerous awards and an honorary degree.

          Dr. Paz received his bachelor’s degree from the University of Rochester, a master of science in life science engineering from Tufts University, and his medical degree from the University of Rochester School of Medicine and Dentistry. He completed his residency at Northwestern University, where he served as chief medical resident and instructor in clinical medicine. He was a Eudowood Fellow in pulmonary and critical care medicine at Johns Hopkins Medical School. In addition, he was a post-doctoral fellow in environmental health science at Johns Hopkins School of Hygiene and Public Health.

        • Jonathan B. Perlin, MD, PhD

          Jonathan B. Perlin, MD, PhD, MSHA, FACP, FACMI is President, Clinical and Physician Services and Chief Medical Officer of Nashville, Tennessee-based HCA (Hospital Corporation of America). He provides leadership for clinical services and improving performance at HCA’s 163 hospitals and more than 600 outpatient centers and physician practices. Current activities include implementing electronic health records throughout HCA, improving clinical “core measures” to benchmark levels, and leading patient safety programs to eliminate preventable complications and healthcare-associated infections.

          Before joining HCA in 2006, “the Honorable Jonathan B. Perlin” was Under Secretary for Health in the U.S. Department of Veterans Affairs. Nominated by the President and confirmed by the Senate, as the senior-most physician in the Federal Government and Chief Executive Officer of the Veterans Health Administration (VHA), Dr. Perlin led the nation’s largest integrated health system. At VHA, Dr. Perlin directed care to over 5.4 million patients annually by more than 200,000 healthcare professionals at 1,400 sites, including hospitals, clinics, nursing homes, counseling centers and other facilities, with an operating and capital budget of over $34 billion. A champion for implementation of electronic health records, Dr. Perlin led VHA quality performance to international recognition as reported in academic literature and lay press and as evaluated by RAND, Institute of Medicine, and others.

          Dr. Perlin has served on numerous Boards and Commissions including the National Quality Forum, the Joint Commission, Meharry Medical College, and he chairs the HHS Health IT Standards Committee. Broadly published in healthcare quality and transformation, he is a Fellow of the American College of Physicians and the American College of Medical Informatics. Dr. Perlin has a Master’s of Science in Health Administration and received his Ph.D. in pharmacology (molecular neurobiology) with his M.D. as part of the Physician Scientist Training Program at the Medical College of Virginia of Virginia Commonwealth University (VCU).

          Perennially recognized as one of the most influential physician executives in the United States by Modern Healthcare, Dr. Perlin has received numerous awards including Distinguished Alumnus in Medicine and Health Administration from his alma mater, Chairman’s Medal from the National Patient Safety Foundation, the Founders Medal from the Association of Military Surgeons of the United States, and is one of nine honorary members of the Special Forces Association and Green Berets.

          Dr. Perlin has faculty appointments at Vanderbilt University as Adjunct Professor of Medicine and Biomedical Informatics and at VCU as Adjunct Professor of Health Administration. He resides in Nashville, Tennessee, with his wife, Donna, an Emergency Pediatrics Physician, and children, Ben and Sarah.

        • Richard Platt, MD, MS

          Richard Platt, MD, MSc is Professor and Chair of the Harvard Medical School Department of Population Medicine at the Harvard Pilgrim Health Care Institute. He is principal investigator of the FDA’s Mini-Sentinel program, of contracts with FDA’s Center for Drugs Evaluation and Research and Center for Biologics Evaluation and Research to conduct post-marketing studies of drugs’ and biologics’ safety and effectiveness. Dr. Platt is also principal investigator of a CDC Prevention Epicenter, a CDC Center of Excellence in Public Health Informatics, and an Agency for Healthcare Research and Quality (AHRQ) HMO Research Network DEcIDE Center. He chaired the FDA’s Drug Safety and Risk Management Advisory Committee, is a member of the Association of American Medical Colleges’ Advisory Panel on Research. Dr. Platt was co-chair of the Board of Scientific Counselors of the Centers for Disease Control and Prevention’s (CDC) Center for Infectious Diseases. Additionally, he chaired the National Institutes of Health study section, Epidemiology and Disease Control 2, and the CDC Office of Health Care Partnerships steering committee.

        • Richard J. Pollack, MPA

          Richard J. Pollack, MPA, began his professional career in Washington, D.C. in 1976 when he served as a legislative assistant to Congressman David Obey of Wisconsin. He left Capitol Hill to become a lobbyist, and enter the health care field, when he signed on with the American Nurses Association to become their legislative representative in the early 1980’s. He went on to join the American Hospital Association’s Washington Office, where he has been a member of the AHA’s advocacy team for the past 29 years. Since 1991, Mr. Pollack has served as executive vice president. In this capacity, he is responsible for the development, implementation and management of the association’s advocacy, representation and public affairs activities, which were recently cited by Fortune magazine as one of the top 25 most influential and effective lobbying organizations in Washington. Mr. Pollack holds a Bachelors Degree in political science and communications from the State University of New York’s College at Cortland. He also earned a Masters Degree in Public Administration from the American University in Washington, D.C. He is married and has two children.

        • Peter J. Pronovost, MD, PhD, FCCM

          Peter Pronovost, MD, PhD, FCCM, is a world-renowned patient safety champion and a practicing critical care physician. His scientific work leveraging checklists to reduce catheter-related bloodstream infections has saved thousands of lives and earned him high-profile accolades, including being named one of the 100 most influential people in the world by Time Magazine and receiving a coveted MacArthur Foundation “genius grant” in 2008. Elected to the Institute of Medicine in 2011, Dr. Pronovost is an advisor to the World Health Organizations’ World Alliance for Patient Safety and regularly addresses the U.S. Congress on patient safety issues. He is Senior Vice President of Patient Safety and Quality and the Director of the Armstrong Institute for Patient Safety and Quality at Johns Hopkins Medicine.

          • John W. Rowe, MD

            John Rowe, MD is a Professor in the Department of Health Policy and Management at the Columbia University Mailman School of Public Health. Previously, from 2000 until his retirement in late 2006, Dr. Rowe served as Chairman and CEO of Aetna, Inc., one of the nation’s leading health care and related benefits organizations. Before his tenure at Aetna, from 1988 to 2000, Dr. Rowe served as President and Chief Executive Officer of Mount Sinai NYU Health, one of the nation’s largest academic health care organizations. From 1988 to 1998, prior to the Mount Sinai-NYU Health merger, Dr. Rowe was President of the Mount Sinai Hospital and the Mount Sinai School of Medicine in New York City.

            Before joining Mount Sinai, Dr. Rowe was a Professor of Medicine and the founding Director of the Division on Aging at the Harvard Medical School, as well as Chief of Gerontology at Boston’s Beth Israel Hospital. He has authored over 200 scientific publications, mostly on the physiology of the aging process, including a leading textbook of geriatric medicine, in addition to more recent publications on health care policy. Dr. Rowe has received many honors and awards for his research and health policy efforts regarding care of the elderly. He was Director of the MacArthur Foundation Research Network on Successful Aging and is co-author, with Robert Kahn, Ph.D., of Successful Aging (Pantheon, 1998). Currently, Dr. Rowe leads the MacArthur Foundation’s Network on An Aging Society.

            He has served as president of the Gerontological Society of America and recently chaired the Committee of the Institute of Medicine of the National Academy of Sciences on The Future Health Care Workforce Needs of An Aging Population. Dr. Rowe was elected a Fellow of the American Academy of Arts and Sciences and a member of the Institute of Medicine of the National Academy of Sciences where he is involved in the Evidence Based Roundtable. Dr. Rowe serves on the Board of Trustees of the Rockefeller Foundation and is Chairman of the Board of Trustees at the Marine Biological Laboratory in Woods Hole, Massachusetts. Dr Rowe is a former member of the Medicare Payment Advisory Commission (MedPAC).

          • Craig E. Samitt, MD, MBA, FACP

            Craig E. Samitt, MD, MBA, FACP, is executive vice president and chief clinical officer for Anthem, Inc., and is responsible for establishing, leading and executing Anthem’s overall clinical vision and strategy. Dr. Samitt oversees Anthem’s clinical operations including: health care analytics, corporate medical and pharmacy policy, health care management and quality, program integrity, and community health initiatives. He is also responsible for advancing Anthem’s industry-leading portfolio of provider partnerships and payment innovation models, focused on improving patient outcomes and delivering value-based care to Anthem’s 38.6 million medical members. Additionally, Dr. Samitt has responsibility for HealthCore, Anthem’s clinical outcomes research subsidiary, and AIM Specialty Health, Anthem’s specialty benefits management subsidiary focused on promoting evidence-based care in high-risk, high-cost areas such as imaging, oncology, and specialty pharmaceuticals. Prior to joining Anthem, Dr. Samitt served as partner and global provider practice leader of Oliver Wyman’s Health & Life Sciences division, and president and chief executive officer for HealthCare Partners, a subsidiary of DaVita HealthCare, one of the largest physician-centric delivery systems in the country. Much of Dr. Samitt’s leadership career was spent as president and CEO of Dean Health System, Inc., one of the largest integrated health systems in the Midwest. Dr. Samitt led a transformation of Dean’s performance, resulting in the escalation of the system’s statewide WCHQ quality ranking from No. 5 to No. 2, driving 16 sequential quarters of improvement in patient satisfaction scores; reducing a three-year medical cost trend to 48 percent of national commercial health plan averages, and receiving recognition by CMS as a 5-star Medicare Plan, and by JD Power as No. 1 health plan in the Midwest for three consecutive years. Dr. Samitt is a nationally recognized health care policy expert and thought leader with a record of collaborating across the health care system to develop and advance solutions that deliver higher-quality health care at a lower cost. He serves on the Board of Directors of the National Committee for Quality Assurance and is currently serving a second three-year term as a Commissioner for MedPAC, an influential, independent legislative branch agency established and appointed by the U.S. Government Accountability Office to advise Congress on policies governing health plans and health care providers serving America’s Medicare beneficiaries. Dr. Samitt previously served on the Boards of Advocate Physicians Partners, Tandigm Health, the Wisconsin Statewide Health Information Network, the Wharton Healthcare Alumni Association, and the Patient-Centered Primary Care Collaborative Center for Accountable Care. He lectures extensively about the transformation of U.S. health care and serves as an annual faculty lecturer at the Wharton School of Business.

            Dr. Samitt earned his undergraduate degree from Tufts University, medical degree from Columbia University, and MBA in health care management from the Wharton School of Business. He completed medical residency in Internal Medicine at Boston’s Brigham and Women’s Hospital.

            • Lewis G. Sandy, MD

              Lewis G. Sandy, MD, is Executive Vice President, Clinical Advancement, UnitedHealth Group (a Fortune 25 diversified health and well-being company dedicated to helping people live healthier lives). At UnitedHealth Group he focuses on clinical innovation, payment/delivery reforms to modernize our health care system, and physician collaboration. He also is a Principal in the UnitedHealth Center for Health Reform and Modernization, with a focus on payment/delivery innovation and policy. From 2003 to 2007, he was EVP and Chief Medical Officer of UnitedHealthcare, UnitedHealth Group’s largest business focusing on the employer/individual health benefits market. From 1997 to 2003, he was EVP of The Robert Wood Johnson Foundation. At RWJF, he was responsible for the Foundation’s program development and management, strategic planning and administrative operations. Prior to this, Dr. Sandy was a program VP of the Foundation, focusing on the Foundation’s workforce, health policy, and chronic care initiatives. An internist and former health center medical director at the Harvard Community Health Plan in Boston, Massachusetts, Dr. Sandy received his B.S. and M.D. degrees from the University of Michigan and an M.B.A. degree from Stanford University. A former RWJF Clinical Scholar and Clinical Fellow in Medicine at the University of California, San Francisco, Dr. Sandy served his internship and residency at the Beth Israel Hospital in Boston. He is a Senior Fellow of the University of Minnesota School of Public Health, Department of Health Policy and Management.

              • Leonard D. Schaeffer

                Leonard D. Schaeffer is the founding Chairman & CEO of WellPoint, the nation’s largest health benefits company by membership. WellPoint serves over 36 million medical members and has annualized revenues of $60 billion. He is currently the Judge Robert Maclay Widney Chair and Professor at the University of Southern California and is a Senior Advisor to TPG Capital, a private equity firm. Schaeffer was Chairman & CEO of WellPoint from 1992 through 2004 and continued to serve as Chairman through 2005. Under his leadership, WellPoint was selected by FORTUNE magazine as America’s “Most Admired Health Care Company” for six consecutive years; named by BusinessWeek as one of the 50 best performing public companies for three consecutive years; and identified by Forbes magazine as America’s best large health insurance company. Mr. Schaeffer was selected by BusinessWeek magazine as one of the “Top 25 Managers of the Year” and by Worth magazine as one of the “50 Best CEOs in America.” In 1986, Mr. Schaeffer was recruited as CEO to WellPoint’s predecessor company, Blue Cross of California, when it was near bankruptcy. He managed the turnaround of Blue Cross of California and the IPO creating WellPoint in 1993. During his tenure as CEO, WellPoint made 17 acquisitions and its value grew from $11 million to over $49 billion. In 2009, Mr. Schaeffer established a new research center at USC. The Schaeffer Center for Health Policy and Economics emphasizes an interdisciplinary approach to research and analysis to promote health and value in health care delivery and to support evidence-based health policy. He has also endowed chairs in health care financing and policy at The Brookings Institution, U.C. Berkeley, the Institute of Medicine and Harvard Medical School. Previously, Mr. Schaeffer was President and CEO of Group Health, Inc. of Minnesota, a staff model HMO. Mr. Schaeffer was also EVP and COO of the Student Loan Marketing Association, the national secondary market for student loans and earlier was a Vice President of Citibank and a consultant specializing in design and installation of large scale financial and management information systems. In the federal government, he served as Administrator of the Health Care Financing Administration (now CMS) and was responsible for the U.S. Medicare and Medicaid programs. He was also the Assistant Secretary for Management and Budget of the federal Department of Health and Human Services. Previously, Mr. Schaeffer was Director of the Bureau of the Budget for the State of Illinois and also served as Chairman of the Illinois Capital Development Board and as Deputy Director for Management, Illinois Department of Mental Health and Developmental Disabilities. Mr. Schaeffer is active on the boards of numerous businesses, philanthropic and professional organizations. He received the inaugural USC Sol Price Award for his lifetime achievements as a business leader, policy expert and philanthropist. He was the Regent’s Lecturer at the University of California at Berkeley and a Gilbert Fellow at Princeton. A native of Evanston, Illinois, he is a graduate of Princeton University. Mr. Schaeffer and his wife, the former Pamela Sidford, have two children.

              • Joe Selby, MD, MPH

                Joe V. Selby, MD, MPH, is the first Executive Director of the Patient-Centered Outcomes Research Institute (PCORI). A family physician, clinical epidemiologist and health services researcher, he has more than 35 years of experience in patient care, research and administration. He will identify strategic issues and opportunities for PCORI and implement and administer the research agenda authorized by the PCORI Board of Governors. Building on the work of the Board and interim staff, Dr. Selby will lead the organizational development of PCORI, which was established by Congress through the 2010 Patient Protection and Affordable Care Act. In addition to creating an organizational structure to carry out a national research agenda, Dr. Selby will lead PCORI’s external communications, including work to establish effective two-way communication channels with the public and stakeholders about PCORI’s work. Dr. Selby joined PCORI from Kaiser Permanente, Northern California, where he was Director of the Division of Research for 13 years and oversaw a department of more than 50 investigators and 500 research staff working on more than 250 ongoing studies. He was with Kaiser Permanente for 27 years. An accomplished researcher, Dr. Selby has authored more than 200 peer-reviewed articles and continues to conduct research, primarily in the areas of diabetes outcomes and quality improvement. His publications cover a spectrum of topics, including effectiveness studies of colorectal cancer screening strategies; treatment effectiveness, population management and disparities in diabetes mellitus; primary care delivery and quality measurement. Dr. Selby was elected to membership in the Institute of Medicine in 2009. A native of Fulton, Missouri, Dr. Selby received his medical degree from Northwestern University; his training in family medicine from Contra Costa County Medical Center, Martinez, CA, and his master’s in public health from the University of California, Berkeley. He was a commissioned officer in the Public Health Service from 1976-1983 and received the Commissioned Officer’s Award in 1981. He serves as Lecturer in the Department of Epidemiology and Biostatistics, University of California, San Francisco School of Medicine, and as a Consulting Professor, Health Research and Policy, Stanford University School of Medicine. Dr. Selby was appointed PCORI executive director on May 16, 2011.

              • Mark D. Smith, MD, MBA

                Mark Smith, MD, MBA, has been President and Chief Executive Officer of the California HealthCare Foundation since its formation in 1996. The Foundation is an independent philanthropy with assets of more than $700 million, headquartered in Oakland, California and dedicated to improving the health of the people of California through its program areas: Better Chronic Disease Care, Innovations for the Underserved, Market and Policy Monitor, and Health Reform and Public Programs Initiative.

                A board-certified internist, Dr. Smith is a member of the clinical faculty at the University of California, San Francisco and an attending physician at the Positive Health Program (for AIDS care) at San Francisco General Hospital. He has been elected to the Institute of Medicine.

                Prior to joining the California HealthCare Foundation, Dr. Smith was Executive Vice President at the Henry J. Kaiser Family Foundation. He previously served as Associate Director of AIDS Services and Assistant Professor of Medicine and of Health Policy and Management at Johns Hopkins University. He has served on the Performance Measurement Committee of the National Committee for Quality Assurance and the editorial board of the Annals of Internal Medicine.

                Dr. Smith received a Bachelor’s degree in Afro-American studies from Harvard College, a Medical Doctorate from the University of North Carolina at Chapel Hill, and a Master’s of Business Administration, with a concentration in Health Care Administration, from the Wharton School at the University of Pennsylvania.

                • Jennifer Taubert, MBA

                  Jennifer Taubert, MBA, is currently Company Group Chairman at Johnson & Johnson, with responsibility for its Janssen Pharmaceutical Companies in North America. A member of the Pharmaceuticals Group Operating Committee, she is responsible for all commercial pharmaceutical operations throughout North America and partners closely with Research & Development and other strategic functions to advance the companies’ small molecule pharmaceutical and biologics portfolio. She assumed the Company Group Chairman role in January 2012. A seasoned global pharmaceutical executive focused on meeting the medical needs of patients, Ms. Taubert has a proven track record in building new businesses, market development and global brand commercialization, and in delivering sustainable, innovation-based growth. Most recently, Ms. Taubert served as President, Internal Medicine, within the Janssen North America commercial organization. In this role, Ms. Taubert led the U.S. Cardiovascular, Metabolics, Pain, Anti-Infectives, Gastrointestinal and Women’s Health businesses as well as the pharmaceutical businesses in Canada and Puerto Rico. Ms. Taubert has significant commercial leadership experience, having served as the General Manager for several divisions of Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc. and the McNeil Pediatrics Division, where she had responsibility for the U.S. Cardiovascular, Institutional and CNS businesses. Prior to that, Ms. Taubert was the Worldwide Vice President, Pharmaceuticals Group Strategic Marketing. She joined the Johnson & Johnson Family of Companies in 2005, having previously worked at Merck & Co., Inc., and Allergan, Inc. Ms. Taubert received her undergraduate degree in Pharmacology from the University of California, Santa Barbara and earned an MBA from the Anderson Graduate School of Management at the University of California, Los Angeles. She serves on the Board of Directors for the American Red Cross of Central New Jersey.

                • Marta Tellado, PhD, MA

                  Marta Tellado, PhD, MA, joined Consumer Reports in the fall of 2014 as President and Chief Executive Officer of Consumer Reports, the largest and most-trusted nonprofit consumer organization in the world. She began her career in the consumer movement and has 25 years of experience as a frontlines advocate and leader for social justice. She is the organization’s eighth president since its founding in 1936. Over its more than 75-year history, Consumer Reports has achieved substantial gains for consumers through its advocacy on health reform, food and product safety, financial reform, and other consumer issues at the federal, state and local level. The organization has advanced important policies to cut hospital-acquired infections, prohibit predatory lending practices and combat dangerous toxins in foods. Consumer Reports accepts no advertising, payment or other support from the companies whose products it evaluates. There are more than 8 million subscribers to its flagship Consumer Reports magazine, website ConsumerReports.org, and other information products. Dr.Tellado is known as a transformational leader with a talent for innovation, a lifelong commitment to social justice and a distinguished portfolio of accomplishments in mission-driven organizations. Dr.Tellado came to Consumer Reports from the Ford Foundation in New York, where she was Vice President for Global Communications and an officer of the board. While there, she led strategic communications and advocacy on a range of social-justice issues in the United States and around the world, including economic fairness, free and fair access to an open Internet, and civil rights. Born in Cuba and raised in New Jersey, Dr.Tellado began her career in public policy, advocacy, and social justice working alongside consumer advocates Ralph Nader and Joan Claybrook at Public Citizen. Since then, she has served as Executive Director of the Domestic Policy Group at the Aspen Institute; as Director for National Issues and Outreach for Senator Bill Bradley; and as Vice President of the Partnership for Public Service, where she launched the Best Places to Work in the federal government and the Service to America awards. Marta holds an MA and PhD in political science from Yale University.

                • Reed V. Tuckson, MD

                  Reed V. Tuckson, MD, FACP, a graduate of Howard University, Georgetown University School of Medicine, and the Hospital of the University of Pennsylvania’s General Internal Medicine Residency and Fellowship Programs, is currently Executive Vice President and Chief of Medical Affairs at UnitedHealth Group, a Fortune 25 diversified health and well-being company. As the senior clinician of UnitedHealth Group, Dr. Tuckson is responsible for working with the company’s diverse and comprehensive business units to improve the quality and efficiency of the health services we provide to the 75 million members we are privileged to serve worldwide.

                  Formerly, Dr. Tuckson served as Senior Vice President, Professional Standards, for the American Medical Association (AMA). He is former President of the Charles R. Drew University of Medicine and Science in Los Angeles; has served as Senior Vice President for Programs of the March of Dimes Birth Defects Foundation; and is a former Commissioner of Public Health for the District of Columbia.

                  Dr. Tuckson is an active member of the prestigious Institute of Medicine of the National Academy of Sciences and he is past Chair of the Secretary of Health and Human Services’ Advisory Committee on Genetics, Health and Society.

                  Dr. Tuckson currently serves on the Board of Directors for several national organizations including the Alliance for Health Reform; the American Telemedicine Association; the National Patient Advocate Foundation; the Arnold P. Gold Foundation; Project Sunshine; Cell Therapeutics, Inc. and Howard University. Additionally, he serves on several Boards within his local community of Minneapolis, including Big Brothers Big Sisters of the Greater Twin Cities and Minnesota Public Radio.

                  Dr. Tuckson has also held other federal appointments, including cabinet level advisory committees on health reform, infant mortality, children’s health, violence, and radiation testing.

                  Dr. Tuckson authored The Doctor in the Mirror, a book and media presentation focused on patient empowerment to overcome everyday health issues for Americans 55 and older, released in November, 2011.

                  He has been selected as one of Modern Healthcare/Modern Physician “50 Most Powerful Physician Executives” in Healthcare and one of the “Top 25 Minority Executives” in Healthcare. He was also designated as Ebony magazine’s “2008 Power 150: The Most Influential Blacks in America” list.

                • Debra B. Whitman, PhD, MA

                  Debra Whitman, PhD, is AARP’s Executive Vice President, Policy and International. Dr. Whitman is an authority on aging issues with extensive experience in national policymaking, domestic and international research and the political process. Dr. Whitman oversees AARP’s Public Policy Institute, Office of Policy Integration, Office of International Affairs and Office of Academic Affairs. She works closely with the Board and National Policy Council on a broad agenda to develop AARP policy priorities and make life better for older Americans. An economist, Dr. Whitman is a strategic thinker whose career has been dedicated to solving problems affecting economic and health security, and other issues related to population aging. As Staff Director for the U.S. Senate Special Committee on Aging, she worked to increase retirement security, preserve a strong system of Social Security, lower the cost of health care, protect vulnerable seniors, safeguard consumers, make the pharmaceutical industry more transparent and improve our nation’s nursing homes. Dr. Whitman has sought bipartisan, fact-based solutions to these and other challenges facing older Americans. Before that, Dr. Whitman worked for the Congressional Research Service as a specialist in the economics of aging. In this capacity, she provided members of Congress and their staff with research and advice and authored analytical reports describing the economic impacts of current policies affecting older Americans, as well as the distributional and intergenerational effects of legislative proposals. From 2001 to 2003, she served as a Brookings LEGIS Fellow to the Senate Health, Education, Labor and Pensions Committee, working as a health policy adviser to Senator Edward M. Kennedy. Earlier in her career, she conducted research on savings and retirement for the Social Security Administration, helping to establish the Retirement Research Consortium and serving as the founding editor of the Perspectives section of the Social Security Bulletin. Dr. Whitman holds a Masters and Doctorate in Economics from Syracuse University and Bachelors in Economics, Math and Italian from Gonzaga University.

                Ex Officio

                • Carolyn M. Clancy, MD

                  Dr. Clancy serves as the Executive in Charge, Veterans Health Administration (VHA), with the authority to perform the functions and duties of the Under Secretary for Health. She was previously the Interim Under Secretary for Health from 2014-2015. She is a highly experienced and nationally recognized physician executive. As the Executive in Charge, Dr. Clancy directs a health care system with an annual budget of approximately $68 billion, overseeing the delivery of care to more than 9 million enrolled Veterans. VHA is the largest integrated health care system in the United States, providing care at 1,243 health care facilities, including 170 VA Medical Centers and 1,063 outpatient sites of care of varying complexity (VHA outpatient clinics) to over 9,000,000 Veterans enrolled in the VA health care program. VHA is the nation’s largest provider of graduate medical education and a major contributor to medical and scientific research. More than 73,000 active volunteers, 127,000 health professions trainees, and more than 306,000 full time health care professionals and support staff are an integral part of the VHA community.

                  Prior to her current position, she served as the Deputy Under Secretary for Health for Organizational Excellence overseeing VHA’s performance, quality, safety, risk management, systems engineering, auditing, oversight, ethics and accreditation programs, as well as ten years as the Director, Agency for Healthcare Research and Quality. In 2015, Dr. Clancy was selected as the Outstanding Federal Executive of the Year by Disabled American Veterans.

                  Dr. Clancy, a general internist and health services researcher, is a graduate of Boston College and the University of Massachusetts Medical School. She holds an academic appointment at George Washington University School of Medicine and serves as Senior Associate Editor, Health Services Research. Dr. Clancy has contributed to eight academic text books and authored, co-authored and provided invited commentary in more than 225 scholarly journal articles. She served as member of the National Quality Forum, Board of Directors, as the Chair of the AQA Alliance and served on the Board of Governors, Patient-Centered Outcomes Research Institute. An elected member of the National Academy of Medicine, Dr. Clancy was most recently presented with the 2014 Quality Champion Award, National Committee for Quality Assurance and was also named as Honorary Fellow, American Academy of Nursing.

                • Francis Collins, MD, PhD

                  Francis S. Collins, MD, PhD, is the director of the National Institutes of Health (NIH). Dr. Collins, a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the Human Genome Project, served as director of the National Human Genome Research Institute (NHGRI) at the NIH from 1993-2008. With Dr. Collins at the helm, the Human Genome Project consistently met projected milestones ahead of schedule and under budget. This remarkable international project culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. On March 10, 2010, Dr. Collins was named a co-recipient of the Albany Medical Center Prize in Medicine and Biomedical Research for his leading role in this effort. In addition to his achievements as the NHGRI director, Dr. Collins’ own research laboratory has discovered a number of important genes, including those responsible for cystic fibrosis, neurofibromatosis, Huntington’s disease, a familial endocrine cancer syndrome, and most recently, genes for type 2 diabetes and the gene that causes Hutchinson-Gilford progeria syndrome. Dr. Collins received a B.S. in chemistry from the University of Virginia, a Ph.D. in physical chemistry from Yale University, and an M.D. with honors from the University of North Carolina at Chapel Hill. Prior to coming to the NIH in 1993, he spent nine years on the faculty of the University of Michigan, where he was a Howard Hughes Medical Institute investigator. He is an elected member of the Institute of Medicine and the National Academy of Sciences. Dr. Collins was awarded the Presidential Medal of Freedom in 2007. In a White House ceremony on October 7, 2009, Dr. Collins received the National Medal of Science, the highest honor bestowed on scientists by the United States government.

                • Admiral Brett P. Giroir, MD

                  Admiral Brett P. Giroir, MD, was sworn in as Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS) on February 15, 2018. The Assistant Secretary for Health leads development of HHS-wide public health policy recommendations, oversees 11 core public health offices — including the Office of the Surgeon General and the U.S. Public Health Service Commissioned Corps, which has approximately 6,500 uniformed health officers who serve in nearly 600 locations around the world to promote, protect and advance the health and safety of our nation and our world. He also oversees three Presidential and 11 Secretarial advisory committees.

                  Dr. Giroir is a physician, scientist and innovator. He is a former medical school executive and biotech startup CEO, and has served in a number of leadership positions in the federal government as well as academia.

                  In addition, Dr. Giroir serves as Senior Advisor to the Secretary for Mental Health and Opioid Policy. In this capacity, he is responsible for coordinating HHS’s efforts across the Administration to fight America’s opioid crisis.

                  From 2014-2015, Dr. Giroir chaired the Veteran’s Choice Act Blue Ribbon Panel to reform the U.S. Veterans Health System. During the Ebola emergency, he directed the Texas Task Force on Infectious and Disease Preparedness Response.

                  He was executive vice president and CEO of Texas A&M’s Health Science Center from 2013-2015, having earlier served as vice chancellor of strategic initiatives (2011-2013) and vice chancellor for research (2008-2011) for the entire Texas A&M University system. A pediatric critical care physician and a former member of the American Board of Pediatrics, Dr. Giroir cared for critically ill children for 14 years, and was the first chief medical officer of Children’s Medical Center of Dallas (now Children’s Health). He was also a professor at the University of Texas Southwestern Medical Center from 1993-2003, and held a number of positions in academic and hospital leadership.

                  Dr. Giroir has had a significant federal portfolio. He directed the Defense Sciences Office of the Defense Advanced Research Projects Agency (DARPA) from 2006-2008. In this capacity, he worked regularly with the White House, Congress, and NIH, CDC, DHS and CIA leadership on national priorities, strategies and programs. He joined the office in 2004 as deputy director, and between1998 and 2004, was a member of the Defense Sciences Research Council.

                  Dr. Giroir has authored or co-authored almost 100 peer-reviewed scientific publications and holds patents on a number of biomedical inventions. He is the recipient of numerous honors and awards, including the U.S. Secretary of Defense Medal for Outstanding Public Service, the American Heart Association’s President Lyndon Baines Johnson Research Award and the Society of Critical Care Medicine’s Annual Scientific Award. He was the nation’s high school debate champion in 1978. He received a bachelor’s degree in biology from Harvard University in 1982 and a medical degree from the University of Texas Southwestern Medical Center (Dallas) in 1986.

                • Kate Goodrich, MD, MPH

                  Kate Goodrich, MD, MHS, director of the Quality Measurement and Health Assessment Group in the Center for Clinical Standards and Quality (CCSQ), joined the Centers for Medicare and Medicaid Services (CMS) in September 2011. She oversees the implementation of 13 quality measurement and public reporting programs across ambulatory, hospital, and post-acute care settings, as well as implementation of the Electronic Health Record Incentive Program (“Meaningful Use” program). She also leads the CMS effort to develop and implement the CMS quality strategy, and co-leads a department-wide group to align quality measures and quality measurement policies across the U.S. Department of Health and Human Services.

                  Previously, Dr. Goodrich served as a senior advisor to the director of CCSQ and the CMS chief medical officer. From 2010 to 2011 she served as a medical officer in the Office of the Assistant Secretary for Planning and Evaluation (ASPE), where she managed a portfolio of work on comparative effectiveness research and quality measurement and improvement.

                  Dr. Goodrich is a graduate of the Robert Wood Johnson Clinical Scholars Program at Yale University, where she received training in health services research and health policy from 2008 to 2010. From 1998 to 2008, Dr. Goodrich was on the faculty at the George Washington University Medical Center (GWUMC) and served as division director for Hospital Medicine from 2005 to 2008 and chair of the Institutional Review Board from 2004 to 2008. She went to medical school at Louisiana State University in Shreveport, Louisiana, and completed her internal medicine residency and chief medical resident year at GWUMC. She continues to practice clinical medicine as a hospitalist and associate professor of medicine at GWUMC.

                • Scott Gottlieb, MD

                  Scott Gottlieb, MD, was sworn in as the 23rd Commissioner of Food and Drugs on May 11, 2017. Dr. Gottlieb is a physician, medical policy expert, and public health advocate who previously served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and before that, as a senior advisor to the FDA Commissioner.

                  He also worked on implementation of the Medicare drug benefit as a senior advisor to the Administrator of the Centers for Medicare and Medicaid Services, where he supported policy work on quality improvement and the agency’s coverage process, particularly as it related to new medical technologies.

                  In 2013 Dr. Gottlieb was appointed by the Senate to serve on the Federal Health Information Technology Policy Committee, which advises the Department of Health and Human Services on healthcare information technology.

                  Dr. Gottlieb was previously a Resident Fellow at the American Enterprise Institute, and a Clinical Assistant Professor at the New York University School of Medicine in Manhattan, where he also practiced medicine as a hospitalist physician.

                  He completed a residency in internal medicine at the Mount Sinai Medical Center in New York, New York and is a graduate of the Mount Sinai School of Medicine and of Wesleyan University, in Middletown, Connecticut, where he studied Economics.

                • Gopal Khanna, MBA

                  Appointed in May 2017, Director Gopal Khanna, MBA, leads AHRQ’s efforts to meet the Agency’s mission of producing evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and working within the U.S. Department of Health and Human Services and with other Federal, State, and local partners to make sure that the evidence is understood and used.

                  Mr. Khanna possesses a wealth of public-sector experience in Federal and State Government and specializes in data-driven strategies to improve organizational performance. He came to AHRQ from Illinois, where he was director of the FRAMEWORK Project that developed the vision for Illinois’ Healthcare and Human Services Innovation Incubator (HHSi2), an initiative of Governor Bruce Rauner. Mr. Khanna led a cross-functional team to design the build out of a secure data platform to provide a 360-degree view of each person and family who receives state services.

                  Earlier, Mr. Khanna was a member of Minnesota Governor Tim Pawlenty’s Cabinet and the State’s first chief information officer. Prior to that, he served in the second Bush Administration in a number of senior policy positions, including chief information officer and chief financial officer for the Peace Corps, and chief financial officer of the Executive Office of the President’s Office of Administration.

                  Before Government service, Mr. Khanna held a variety of executive positions in the insurance industry. His private sector background also includes leadership positions in information technology, finance, operations, strategic planning, business development, consulting, and start-up ventures.

                  Mr. Khanna earned a bachelor’s degree in economics, mathematics, and political science from Christ Church College in Kanpur, India, and a master’s of business administration from the University of Maine. Mr. Khanna served as president of the National Association of State CIOs from 2008 to 2009.

                  He is a recipient of the prestigious 2018 FedHealthIT 100 Award and has been recognized for his innovative and transformational work in government in publications including Computerworld, Government Technology, Information Week and Twin Cities Business. Mr. Khanna was also named as a Doer, Dreamer, and Driver in Government Technology‘s listing of Top 25 public sector innovators.

                • Michael Lauer, MD

                  Michael Lauer, M.D., is the Deputy Director for Extramural Research at the National Institutes of Health (NIH), where he serves as the principal scientific leader and advisor to the Director of the NIH on all matters relating to the substance, quality, and effectiveness of the NIH extramural research program and administration. He received education and training at Rensselaer Polytechnic Institute, Albany Medical College, Harvard Medical School, Harvard School of Public Health, and the NHLBI’s Framingham Heart Study. He spent 14 years at Cleveland Clinic as Professor of Medicine, Epidemiology, and Biostatistics. During his tenure at the Clinic, he led a federally funded internationally renowned clinical epidemiology program that applied big data from large-scale electronic health platforms to questions regarding the diagnosis and management of cardiovascular disease. From 2007 to 2015 he served as a Division Director at the National Heart, Lung, and Blood Institute (NHLBI), where promoted efforts to leverage big data infrastructure to enable high-efficiency population and clinical research and efforts to adopt a research funding culture that reflected data-driven policy. He has received numerous awards including the NIH Equal Employment Opportunity Award of the Year and the Arthur S. Flemming Award for Exceptional Federal Service in recognition of his efforts to grow a culture of learning and accountability.

                • Tom McCaffery, MPP

                  Tom McCaffery, MPP, was sworn in as the Principal Deputy Assistant Secretary of Defense for Health Affairs on August 23, 2017.  Immediately upon his swearing in, he became the Acting Assistant Secretary of Defense for Health Affairs pending the nomination and confirmation of a candidate for that position.

                  In this role, Mr. McCaffery is the principal medical advisor to the Secretary of Defense. He administers the Military Health System (MHS) $50 billion Defense Health Program (DHP) budget and is responsible for ensuring the global delivery of quality, cost effective health care to 9.4 million Service Members, retirees, and their families.  Mr. McCaffery oversees the Defense Health Agency and the Uniformed Services University of the Health Sciences.

                  Mr. McCaffery has extensive experience in the health care industry.  Most recently, he served as Vice President, California State Partnerships at Blue Shield of California.  In this capacity, he led the day-to-day activities governing Blue Shield’s post-acquisition integration of the Care1st Health Plan, a 500,000 member health plan serving Medicaid and Medicare members.  Prior to that role, he served as Vice President of Blue Shield’s CalPERS sector, where he led a team responsible for all strategic initiatives, product development, marketing, pricing, and operational functions for the 400,000 member California Public Employees Retirement System (CalPERS) account.

                  Prior to his tenure at Blue Shield, he served as Chief Deputy Director of the California Department of Health Services, California’s public health and health care services agency.  Mr. McCaffery also served as Senior Vice President / Chief Operating Officer at the Alliance of Catholic Health Care, the public policy and advocacy organization representing California’s Catholic health systems and hospitals.  Earlier in his career, he served on the staff of the Washington, DC Office of the Governor of California.

                  Active in many community organizations, Mr. McCaffery has served on a number of healthcare, education and children’s program non-profits in the Sacramento area.

                  Mr. McCaffery graduated from the University of Notre Dame with a degree in Government and International Relations and holds a Master’s Degree in Public Policy from the University of California at Berkeley.

                • Robert R. Redfield, MD

                  Robert R. Redfield, MD, is the 18th Director of the Centers for Disease Control and Prevention and Administrator of the Agency for Toxic Substances and Disease Registry. He has been a public health leader actively engaged in clinical research and clinical care of chronic human viral infections and infectious diseases, especially HIV, for more than 30 years.

                  He served as the founding director of the Department of Retroviral Research within the U.S. Military’s HIV Research Program, and retired after 20 years of service in the U.S. Army Medical Corps. Following his military service, he co-founded the University of Maryland’s Institute of Human Virology with Dr. William Blattner and Dr. Robert C. Gallo and served as the Chief of Infectious Diseases and Vice Chair of Medicine at the University of Maryland School of Medicine.

                  Dr. Redfield made several important early contributions to the scientific understanding of HIV, including the demonstration of the importance of heterosexual transmission, the development of the Walter Reed staging system for HIV infection, and the demonstration of active HIV replication in all stages of HIV infection.

                  In addition to his research work, Dr. Redfield oversaw an extensive clinical program providing HIV care and treatment to more than 5,000 patients in the Baltimore/Washington, D.C. community.

                  Dr. Redfield served as a member of the President’s Advisory Council on HIV/AIDS from 2005 to 2009, and was appointed as Chair of the International Subcommittee from 2006 to 2009.

                  He is a past member of the Office of AIDS Research Advisory Council at the National Institutes of Health, the Fogarty International Center Advisory Board at the National Institutes of Health, and the Advisory Anti-Infective Agent Committee of the Food and Drug Administration.

                • Chesley Richards, MD, MPH, FACP

                  Chesley Richards, MD, MPH, FACP, is the CDC Deputy Director for the Office of Public Health Scientific Services (OPHSS). OPHSS is comprised of the National Center for Health Statistics and the Center for Surveillance, Epidemiology and Laboratory Services (CSELS). Previously, Dr. Richards served as Director for the Immunization Services Division in the National Center for Immunization and Respiratory Diseases at CDC.

                  In these two roles, Dr. Richards is a key advisor to the CDC Director and oversees the National Center for Health Statistics (NCHS) and the Center for Surveillance, Epidemiology and Laboratory Services (CSELS) with activities that include the MMWR, Vital Signs publications, the Epidemic Intelligence Service and other scientific training programs, the Guide to Community Preventive Services, and a broad range of cross cutting epidemiology, public health surveillance, and laboratory services.

                  Dr. Richards earned his M.D. from the Medical University of South Carolina, an M.P.H. in Health Policy and Administration from University of North Carolina at Chapel Hill and is a graduate of the Epidemic Intelligence Service (EIS) at CDC, the Cancer Control Education Fellowship at UNC Lineberger Cancer Center and the Program on Clinical Effectiveness at Harvard School of Public Health.  He completed Internal Medicine (Medical College of Georgia), Geriatric Medicine (Emory University) and General Preventive Medicine and Public Health (UNC Chapel Hill).

                • George Sigounas, MS, PhD

                  George Sigounas, MS, PhD, became Administrator for the U.S. Department of Health and Human Services’ Health Resources and Services Administration (HRSA) on May 1, 2017.

                  Before coming to HRSA, George Sigounas, MS, PhD, spent 23 years as Professor of Medicine at the East Carolina University’s Brody School of Medicine in Greenville, NC where he helped establish the Bone Marrow Transplantation Program. He directed the Cellular Therapies Clinical Unit which provided the Bone Marrow Transplantation Program with the cells used to transplant cancer patients. During this period, he also served as an Inspector for the Foundation for the Accreditation of Cellular Therapy (FACT). FACT is the non-profit corporation that inspects and accredits facilities and programs in the field of cellular therapies worldwide.

                  His work with the Bone Marrow Transplantation Program also provided extensive experience with designing and conducting clinical trials, preparing patient treatment protocols, and performing fiscal management.

                  From 1987-94, Dr. Sigounas was a scientist and researcher at the National Institutes of Health and the Naval Medical Center. Through the years, his research efforts have resulted in several U.S. and international patents as well as peer-reviewed publications.

                  For more than 30 years, Dr. Sigounas has been teaching and training a broad spectrum of students, including undergraduates, graduates, medical students, residents and fellows. He has also been a mentor to numerous junior faculty and worked collaboratively with many clinicians and scientists.

                  Dr. Sigounas earned his bachelor of science degree in biology and chemistry from the University of Patras in Greece, a master of science in physiology and biology from Northeastern University, and a Ph.D. in cell biology and physiology from Boston University.

                • Seema Verma, MPH

                  Ms. Seema Verma was sworn in as the 15th Administrator of the Centers for Medicare and Medicaid Services on March 14, 2017. She brings deep experience in healthcare policy, Medicaid, insurance, and public health to her role at CMS. Ms. Verma is committed to empowering patients to take ownership of their healthcare and ensuring they have access to the resources they need to make informed decisions.

                  For more than two decades, Ms. Verma has guided healthcare policy in the public and private sector. She has worked with states to build flexibility into their Medicaid programs to help them meet the diverse needs of their unique populations.  As the architect of the historic Healthy Indiana Plan, she helped create and implement the Nation’s first consumer-directed Medicaid program.

                  Continuing her efforts to improve health outcomes for all Americans, Ms. Verma is working toward a new era of state flexibility and local leadership at CMS. She aims to reduce burdensome regulations so doctors and providers can focus on providing high quality healthcare to patients. She also supports implementing innovative solutions that will improve healthcare quality, accessibility, and outcomes for states, while driving down costs.

                  Administrator Verma completed a Master’s degree in Public Health with a concentration in health policy and management from Johns Hopkins University and a Bachelor’s degree in Life Sciences from the University of Maryland. Previously she was the President, CEO, and founder of SVC, Inc., a national health policy consulting company.